Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar rofgile (34.32) Submitted: 2/15/2011 5:41:56 PM : Outperform Start Price: $52.24 AMGN Score: +32.80

Biotech watchlist

Report this Post Reply

Featured Broker Partners


Advertisement